Skip to main content
Figure 6 | BMC Cancer

Figure 6

From: Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation

Figure 6

Intensity of VEGF staining of cancer cells from irbesartan sensitive (Irb-sensitive; AT1R LOW ) and insensitive (Irb-insensitive; AT1R HI ) tumours either treated with irbesartan (IRB) or untreated. (A). Counts of high VEGF-expressing infiltrating cells per tumour area (measured at 200x magnification) (B). n = 5 or 6 for each group except for AT1RLOW tumours which, because of the reduced tumour load, had additional samples (n of 10). Between 10 and 30 images were taken from each mouse across 1 to 5 tumours (dependent on tumour load). Representative images showing both the cancer-cell VEGF staining intensity and the high-staining infiltrating cells are shown to the right. Significant P values between 0.01 and 0.05 are shown with an *, those less than 0.01 are shown with **. Data for A are shown as a box plot to illustrate changes in the median values and range while data for B are presented as mean ± S.E.M.

Back to article page